Your journey to a GenAI future: A strategic path to success in life sciences and pharma

As generative AI continues to make waves across both headlines and boardrooms, the life sciences industry is unlocking new possibilities that could reshape the future. This sector, known for managing vast, intricate data sets and safeguarding sensitive patient information, is poised to harness GenAI for groundbreaking advancements. In life sciences, GenAI isn’t just a buzzword – it’s a game changer with the potential to revolutionize innovation, productivity and patient care.

Our latest insights on GenAI come from a comprehensive survey of 1,600 organizations across the globe, offering a deep dive into how different industries are approaching GenAI. Specifically, we focused on the responses of 237 senior life sciences leaders who are at the forefront of shaping GenAI, data and analytics strategy.

In this report, you’ll discover:

• How the life sciences industry is leading or lagging in GenAI adoption compared with other sectors.
• The specific areas where the industry is already seeing GenAI drive results – and where it is still navigating uncertainty.
• How GenAI investments in life sciences stack up against other sectors and where the industry is placing its bets.
• Practical strategies to overcome the challenges of GenAI implementation, ensuring you maximize your return on investment (ROI) and stay ahead of the curve.